Suppr超能文献

勘误：阻断乌索苷B诱导的自噬促生存信号增强其对肝细胞癌的化疗疗效。

Corrigendum: Blockade of uttroside B-induced autophagic pro-survival signals augments its chemotherapeutic efficacy against hepatocellular carcinoma.

作者信息

Nath Lekshmi R, Swetha Mundanattu, Vijayakurup Vinod, Thangarasu Arun Kumar, Haritha Nair Hariprasad, Shabna Anwar, Aiswarya Sreekumar U, Rayginia Tennyson P, Keerthana C K, Kalimuthu Kalishwaralal, Sundaram Sankar, Lankalapalli Ravi Shankar, Pillai Sreekumar, Towner Rheal, Isakov Noah, Anto Ruby John

机构信息

Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.

Chemical Sciences and Technology Division, Council for Scientific and Industrial Research (CSIR)-National Institute for Interdisciplinary Science and Technology, Thiruvananthapuram, India.

出版信息

Front Oncol. 2022 Aug 25;12:991401. doi: 10.3389/fonc.2022.991401. eCollection 2022.

DOI:10.3389/fonc.2022.991401
PMID:36091117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9453749/
Abstract

[This corrects the article DOI: 10.3389/fonc.2022.812598.].

摘要

[本文更正了文章的数字对象标识符：10.3389/fonc.2022.812598。]

相似文献

1
Corrigendum: Blockade of uttroside B-induced autophagic pro-survival signals augments its chemotherapeutic efficacy against hepatocellular carcinoma.勘误：阻断乌索苷B诱导的自噬促生存信号增强其对肝细胞癌的化疗疗效。
Front Oncol. 2022 Aug 25;12:991401. doi: 10.3389/fonc.2022.991401. eCollection 2022.
2
Blockade of Uttroside B-Induced Autophagic Pro-Survival Signals Augments Its Chemotherapeutic Efficacy Against Hepatocellular Carcinoma.阻断乌托苷B诱导的自噬促生存信号可增强其对肝细胞癌的化疗疗效。
Front Oncol. 2022 Feb 8;12:812598. doi: 10.3389/fonc.2022.812598. eCollection 2022.
3
Evaluation of uttroside B, a saponin from Solanum nigrum Linn, as a promising chemotherapeutic agent against hepatocellular carcinoma.评价黑茄中的甾体皂苷 uttroside B 作为一种有前途的肝癌化学治疗药物。
Sci Rep. 2016 Nov 3;6:36318. doi: 10.1038/srep36318.
4
Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma.在人肝细胞癌小鼠模型中，乌索苷B对比索拉非尼的增效作用
Pharmaceuticals (Basel). 2022 May 22;15(5):636. doi: 10.3390/ph15050636.
5
Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma.勘误：上调的LINC01667表达与肝细胞癌的不良预后相关。
Front Oncol. 2021 Oct 15;11:785394. doi: 10.3389/fonc.2021.785394. eCollection 2021.
6
Author Correction: Evaluation of uttroside B, a saponin from Solanum nigrum Linn, as a promising chemotherapeutic agent against hepatocellular carcinoma.作者更正：龙葵皂苷B（一种来自龙葵的皂苷）作为一种有前景的抗肝细胞癌化疗药物的评估。
Sci Rep. 2020 Nov 18;10(1):20431. doi: 10.1038/s41598-020-77440-0.
7
Corrigendum: Accelerating Decreases in the Incidences of Hepatocellular Carcinoma at a Younger Age in Shanghai Are Associated With Hepatitis B Virus Vaccination.勘误：上海年轻人群肝细胞癌发病率加速下降与乙肝疫苗接种有关。
Front Oncol. 2022 Sep 20;12:950499. doi: 10.3389/fonc.2022.950499. eCollection 2022.
8
Chloroquine sensitizes hepatocellular carcinoma cells to chemotherapy via blocking autophagy and promoting mitochondrial dysfunction.氯喹通过阻断自噬和促进线粒体功能障碍使肝癌细胞对化疗敏感。
Int J Clin Exp Pathol. 2017 Sep 1;10(9):10056-10065. eCollection 2017.
9
Corrigendum: Real-World Lenvatinib Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.勘误：晚期肝细胞癌患者中乐伐替尼与索拉非尼的真实世界研究：一项倾向评分匹配分析。
Front Oncol. 2021 Dec 14;11:823960. doi: 10.3389/fonc.2021.823960. eCollection 2021.
10
Corrigendum: A genome-wide investigation of effects of aberrant DNA methylation on the usage of alternative promoters in hepatocellular carcinoma.勘误：肝细胞癌中异常DNA甲基化对可变启动子使用影响的全基因组研究。
Front Oncol. 2023 Aug 31;13:1253552. doi: 10.3389/fonc.2023.1253552. eCollection 2023.

引用本文的文献

1
Solanum nigrum Linn.: Advances in anti-cancer activity and mechanism in digestive system tumors.龙葵：消化系统肿瘤抗癌活性及机制的研究进展。
Med Oncol. 2023 Sep 29;40(11):311. doi: 10.1007/s12032-023-02167-7.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验